In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma
- PMID: 9708927
In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma
Abstract
Background: The rate of incidence of esophageal adenocarcinoma has surpassed that of all other malignancies in the U.S. Esophageal adenocarcinoma arises from Barrett's esophagus through the multistep accumulation of genetic mutations in metaplastic cells, accompanied by histologic changes from metaplasia to low grade and high grade dysplasia and finally to carcinoma. Although telomerase activity has been demonstrated in 85-90% of human cancers, to the authors' knowledge there are no reports regarding esophageal adenocarcinoma. The objective of this study was to determine whether telomerase RNA is increased in esophageal adenocarcinoma and at what point in the histologic progression such an increase occurs.
Methods: Formalin-fixed, paraffin-embedded esophageal biopsies from patients with Barrett's esophagus and surgical resection specimens of esophageal adenocarcinoma containing varying stages of neoplastic progression were obtained. Adjacent sections from each specimen were evaluated by routine histology and in situ hybridization for the RNA component of human telomerase.
Results: The authors found that 100% of esophageal adenocarcinomas and high grade dysplasias were strongly positive for telomerase RNA. Basal crypt cells of Barrett's metaplasia demonstrated weak to moderate telomerase RNA in 70% of cases, whereas 90% of low grade dysplasias had moderate levels of telomerase RNA.
Conclusions: The results of this study showed that 1) Barrett's epithelium may contain a population of immortalized cells, 2) a marked increase in the level of telomerase RNA accompanies the transition from low grade to high grade dysplasia, and 3) high levels of telomerase RNA accompany the development of esophageal adenocarcinoma in the vast majority of cases.
Similar articles
-
Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.Am J Gastroenterol. 2005 Jun;100(6):1257-64. doi: 10.1111/j.1572-0241.2005.41338.x. Am J Gastroenterol. 2005. PMID: 15929754
-
High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.Virchows Arch. 2003 Jan;442(1):18-24. doi: 10.1007/s00428-002-0674-1. Epub 2002 Sep 24. Virchows Arch. 2003. PMID: 12536310
-
p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.Mod Pathol. 2001 May;14(5):397-403. doi: 10.1038/modpathol.3880324. Mod Pathol. 2001. PMID: 11353048
-
Dysplasia arising in barrett's esophagus: diagnostic pitfalls and natural history.Semin Diagn Pathol. 2002 Feb;19(1):12-9. Semin Diagn Pathol. 2002. PMID: 11936261 Review.
-
The molecular biology of esophageal adenocarcinoma.J Surg Oncol. 2005 Dec 1;92(3):169-90. doi: 10.1002/jso.20359. J Surg Oncol. 2005. PMID: 16299787 Review.
Cited by
-
Molecular biology of Barrett's adenocarcinoma.Ann Surg. 2001 Mar;233(3):322-37. doi: 10.1097/00000658-200103000-00005. Ann Surg. 2001. PMID: 11224619 Free PMC article. Review.
-
Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.Am J Pathol. 1999 Apr;154(4):965-73. doi: 10.1016/S0002-9440(10)65346-1. Am J Pathol. 1999. PMID: 10233832 Free PMC article. Review.
-
Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels.Mol Cell Biol. 1999 Jun;19(6):3989-97. doi: 10.1128/MCB.19.6.3989. Mol Cell Biol. 1999. PMID: 10330139 Free PMC article.
-
Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells.Cancer Sci. 2008 Jun;99(6):1092-9. doi: 10.1111/j.1349-7006.2008.00815.x. Cancer Sci. 2008. PMID: 18482052 Free PMC article. Review.
-
Genetics in the pathogenesis of esophageal cancer: possible predictive and prognostic factors.J Gastrointest Surg. 2010 Feb;14 Suppl 1:S75-80. doi: 10.1007/s11605-009-1021-5. Epub 2009 Sep 12. J Gastrointest Surg. 2010. PMID: 19756878
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical